TEL-AVIV, Israel, June 2, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage proprietary drugs for the treatment of inflammatory and gastrointestinal diseases and related conditions, today announced that Guy Goldberg, RedHill’s Chief Business Officer, will be presenting at the Jefferies 2014 Global Healthcare Conference, on Thursday, June 5, 2014, at 13:30 EDT. The conference will be held at the Grand Hyatt, in New York City.
Help employers find you! Check out all the jobs and post your resume.
